Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Axelrod

Showing results (71-80 of 90) with videos related to

Pageof 9
Sort By:
Nuclear Medicine Communications|January 1, 1987
The implications of decreased performance of new generation gamma-cameras on the interpretation of 131I-Hippuran renal imagesL S Zuckier, M S Axelrod, J P Wexler, et al.
Cancer|January 20, 2011
A phase 2 trial of bortezomib followed by the addition of doxorubicin at progression in patients with recurrent or metastatic adenoid cystic carcinoma of the head and neck: a trial of the Eastern Cooperative Oncology Group (E1303)Athanassios Argiris, Musie Ghebremichael, Barbara Burtness, et al.
Psychoneuroendocrinology|January 1, 1989
Hypothalamo-pituitary-adrenal activity in endogenously depressed post-traumatic stress disorder patientsU Halbreich, J Olympia, S Carson, et al.
Cancer Research|December 1, 1979
Lactate metabolism in patients with metastatic colorectal cancerC P Holroyde, R S Axelrod, C L Skutches, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 26, 2015
Reply to D. Adkins et alRita S Axelrod, Eric Sherman, Adam Garden, et al.
Journal of Biological Response Modifiers|April 1, 1990
The effect of a bacterial vaccine on tumors and the immune response of ICR/Ha miceH F Havas, G Schiffman, B Bushnell, et al.
The Behavior Analyst|April 6, 2012
The right to effective behavioral treatmentR Van Houten, S Axelrod, J S Bailey, et al.
Journal of Applied Behavior Analysis|January 1, 1988
The right to effective behavioral treatmentR Van Houten, S Axelrod, J S Bailey, et al.
American Journal of Clinical Oncology|July 9, 2016
Phase I Trial Using Induction Ciplatin, Docetaxel, 5-FU and Erlotinib Followed by Cisplatin, Bevacizumab and Erlotinib With Concurrent Radiotherapy for Advanced Head and Neck CancerPeter H Ahn, Mitchell Machtay, Pramila R Anne, et al.
Seminars in Radiation Oncology|March 28, 2002
Phase II: trial of twice weekly amifostine in patients with non-small cell lung cancer treated with chemoradiotherapyMaria Werner-Wasik, Rita S Axelrod, David P Friedland, et al.
Pageof 9

Showing results (71-80 of 90) with videos related to

Sort By:
Pageof 9
Nuclear Medicine Communications|January 1, 1987
The implications of decreased performance of new generation gamma-cameras on the interpretation of 131I-Hippuran renal imagesL S Zuckier, M S Axelrod, J P Wexler, et al.
Cancer|January 20, 2011
A phase 2 trial of bortezomib followed by the addition of doxorubicin at progression in patients with recurrent or metastatic adenoid cystic carcinoma of the head and neck: a trial of the Eastern Cooperative Oncology Group (E1303)Athanassios Argiris, Musie Ghebremichael, Barbara Burtness, et al.
Psychoneuroendocrinology|January 1, 1989
Hypothalamo-pituitary-adrenal activity in endogenously depressed post-traumatic stress disorder patientsU Halbreich, J Olympia, S Carson, et al.
Cancer Research|December 1, 1979
Lactate metabolism in patients with metastatic colorectal cancerC P Holroyde, R S Axelrod, C L Skutches, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 26, 2015
Reply to D. Adkins et alRita S Axelrod, Eric Sherman, Adam Garden, et al.
Journal of Biological Response Modifiers|April 1, 1990
The effect of a bacterial vaccine on tumors and the immune response of ICR/Ha miceH F Havas, G Schiffman, B Bushnell, et al.
The Behavior Analyst|April 6, 2012
The right to effective behavioral treatmentR Van Houten, S Axelrod, J S Bailey, et al.
Journal of Applied Behavior Analysis|January 1, 1988
The right to effective behavioral treatmentR Van Houten, S Axelrod, J S Bailey, et al.
American Journal of Clinical Oncology|July 9, 2016
Phase I Trial Using Induction Ciplatin, Docetaxel, 5-FU and Erlotinib Followed by Cisplatin, Bevacizumab and Erlotinib With Concurrent Radiotherapy for Advanced Head and Neck CancerPeter H Ahn, Mitchell Machtay, Pramila R Anne, et al.
Seminars in Radiation Oncology|March 28, 2002
Phase II: trial of twice weekly amifostine in patients with non-small cell lung cancer treated with chemoradiotherapyMaria Werner-Wasik, Rita S Axelrod, David P Friedland, et al.
Pageof 9